Testing mosquito release to stop dengue clusters in public housing
Part of Infections clinical trials.
This trial tests a new way to reduce dengue outbreaks by releasing special mosquitoes in public housing areas with active dengue clusters. If your neighborhood has a recent cluster of at least 10 cases, you may be part of the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in a public housing estate.
- Your area has at least 10 dengue cases in a cluster.
- The first 10 cases happened within 30 days of each other.
- Your area has never had Wolbachia mosquito releases.
- Your area is at least 700 meters away from any Wolbachia release zone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
This trial is testing whether a "Mosquito-Free Campus" program can help prevent dengue fever in schools. The program will be set up in primary and middle schools in certain areas of Guangzhou and Foshan cities. If your school is in one of these areas and is willing to take part, this study could show how to keep students safe from dengue.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.